Yuqian Yan

2.6k total citations
37 papers, 1.4k citations indexed

About

Yuqian Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuqian Yan has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Yuqian Yan's work include Ubiquitin and proteasome pathways (9 papers), Prostate Cancer Treatment and Research (8 papers) and Protein Degradation and Inhibitors (7 papers). Yuqian Yan is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Prostate Cancer Treatment and Research (8 papers) and Protein Degradation and Inhibitors (7 papers). Yuqian Yan collaborates with scholars based in United States, China and Australia. Yuqian Yan's co-authors include Haojie Huang, Yunqian Pan, Donglin Ding, Xin Jin, Liguo Wang, Dejie Wang, Tao Ma, Rafael E. Jiménez, Heshui Wu and Robert G. Ramsay and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Yuqian Yan

37 papers receiving 1.3k citations

Peers

Yuqian Yan

ONCOL

PRM

HEMAT

Lesley Mathews United States

Lauren M. Thorpe United States

Davide Pellacani United Kingdom

Georgia Konstantinidou Switzerland

Nicole E. Willmarth United States

Katharine Ellwood‐Yen United States

Ángel Guerrero‐Zotano Spain

Frédéric Commo France

Chee Wee Ong Singapore

Xiao-Feng Le United States

Lesley Mathews United States

Yuqian Yan

862 ×0.8

604 ×1.5

ONCOL

253 ×0.8

PRM

374 ×1.3

127 ×1.1

HEMAT

Citations per year, relative to Yuqian Yan Yuqian Yan (= 1×) peers Lesley Mathews

Countries citing papers authored by Yuqian Yan

Since Specialization

Citations

This map shows the geographic impact of Yuqian Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqian Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqian Yan more than expected).

Fields of papers citing papers by Yuqian Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqian Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqian Yan. The network helps show where Yuqian Yan may publish in the future.

Co-authorship network of co-authors of Yuqian Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqian Yan. A scholar is included among the top collaborators of Yuqian Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqian Yan. Yuqian Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Qingqin, Yuqian Yan, Qi Chen, et al.. (2025). Overcoming barriers in glioblastoma: The potential of CAR T cell immunotherapy. Theranostics. 15(14). 7090–7126. 2 indexed citations

Nesvick, Cody L., Liang Zhang, Yuqian Yan, et al.. (2025). SWI/SNF complexes govern ontology-specific transcription factor function in MYC-subtype atypical teratoid rhabdoid tumor. Neuro-Oncology. 27(9). 2445–2460. 1 indexed citations

Yan, Yuqian, Lu Zhang, Juan Yang, et al.. (2024). Association of exposure to per- and polyfluoroalkyl substances with liver injury in American adults. Journal of Biomedical Research. 38(6). 628–628. 2 indexed citations

Li, Xiang, Bo Tang, Hao Li, et al.. (2023). SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer Research. 83(6). 875–889. 23 indexed citations

Zhou, Yingke, Xin Jin, Jian Ma, et al.. (2021). HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer. Cancer Research. 81(6). 1486–1499. 54 indexed citations

Shi, Lei, Yuqian Yan, Yundong He, et al.. (2021). Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression. Cancer Research. 81(13). 3593–3606. 25 indexed citations

Yan, Yuqian, Donglin Ding, Dejie Wang, et al.. (2021). Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG (Adv. Sci. 20/2021). Advanced Science. 8(20). 1 indexed citations

Ma, Jian, Qing Shi, Gaofeng Cui, et al.. (2021). SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition. Nature Communications. 12(1). 5779–5779. 17 indexed citations

Zhang, Wei, Donglin Ding, Zhenlin Huang, et al.. (2020). DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1. Molecular Cell. 79(6). 1008–1023.e4. 31 indexed citations

10.

Bai, Yang, Yinhui Yang, Yuqian Yan, et al.. (2019). RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis. Theranostics. 9(12). 3459–3475. 14 indexed citations

11.

Ma, Linlin, Yuqian Yan, Yang Bai, et al.. (2019). Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer. Theranostics. 9(17). 5020–5034. 17 indexed citations

12.

He, Yundong, Yinhui Yang, Zhenqing Ye, et al.. (2018). TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer. Clinical Cancer Research. 24(18). 4551–4565. 51 indexed citations

13.

Jin, Xin, Yuqian Yan, Dejie Wang, et al.. (2018). DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4. Molecular Cell. 71(4). 592–605.e4. 124 indexed citations

14.

McKay, Michael J., Jeffrey M. Craig, Paul Kalitsis, et al.. (2018). A Roberts Syndrome Individual With Differential Genotoxin Sensitivity and a DNA Damage Response Defect. International Journal of Radiation Oncology*Biology*Physics. 103(5). 1194–1202. 10 indexed citations

15.

Jin, Xin, Donglin Ding, Yuqian Yan, et al.. (2018). Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. Molecular Cell. 73(1). 22–35.e6. 194 indexed citations

16.

Yang, Yinhui, Dejie Wang, Jian An, et al.. (2017). Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion. Cancer Research. 77(23). 6524–6537. 47 indexed citations

17.

Cheasley, Dane, Lloyd Pereira, Shienny Sampurno, et al.. (2015). Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis. Molecular Cancer Research. 13(8). 1185–1196. 14 indexed citations

18.

Deb, Siddhartha, Huiling Xu, Jurriaan B. Tuynman, et al.. (2014). RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas. British Journal of Cancer. 110(6). 1606–1613. 49 indexed citations

19.

Xu, Huiling, Jordane Malaterre, Matthew D. Beasley, et al.. (2010). Rad21-Cohesin Haploinsufficiency Impedes DNA Repair and Enhances Gastrointestinal Radiosensitivity in Mice. PLoS ONE. 5(8). e12112–e12112. 82 indexed citations

20.

Zheng, Hong, Zhiwu Chen, Lin Wang, et al.. (2007). Radioprotection of 4-hydroxy-3,5-dimethoxybenzaldehyde (VND3207) in culture cells is associated with minimizing DNA damage and activating Akt. European Journal of Pharmaceutical Sciences. 33(1). 52–59. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact